Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 25.72M P/E - EPS this Y 75.20% Ern Qtrly Grth -
Income -8.49M Forward P/E -2.89 EPS next Y -59.00% 50D Avg Chg 6.00%
Sales 4.8M PEG - EPS past 5Y - 200D Avg Chg -21.00%
Dividend N/A Price/Book 0.80 EPS next 5Y - 52W High Chg -65.00%
Recommedations 1.50 Quick Ratio 12.40 Shares Outstanding 5.35M 52W Low Chg 50.00%
Insider Own 2.91% ROA -22.67% Shares Float 5.19M Beta 1.21
Inst Own 9.96% ROE -34.12% Shares Shorted/Prior 138.80K/141.39K Price 4.94
Gross Margin 100.00% Profit Margin -176.80% Avg. Volume 176,457 Target Price 21.50
Oper. Margin -3,676.18% Earnings Date Nov 6 Volume 25,034 Change -0.60%
About Lipocine Inc.

Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders. Its lead product candidate is TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate. The company's pipeline candidates also include TLANDO XR a candidate for oral TRT for once daily dosing, which has completed Phase 2b clinical study; LPCN 1148, an oral prodrug of bioidentical testosterone, being developed for the treatment of cirrhosis, currently under Phase 2 clinical studies; LPCN 1154, An oral neurosteroid, being developed for the treatment of postpartum depression, currently under Phase 2 studies; LPCN 2101, a NAS candidate, for women with epilepsy; and LPCN 2203 for essential tremor. It is also involved in the development of LPCN 1144, an oral prodrug of bioidentical testosterone for the treatment of pre-cirrhotic non-alcoholic steatohepatitis, which has completed Phase 2 testing; and LPCN 1107, an oral product candidate of 17-alpha-hydroxy progesterone caproate product, currently under Phase 3 studies for the prevention of recurrent preterm birth. The company was founded in 1997 and is headquartered in Salt Lake City, Utah.

Lipocine Inc. News
11/18/24 Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session
11/07/24 Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2024
11/07/24 Lipocine: Q3 Earnings Snapshot
10/31/24 Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO® in South Korea
10/10/24 Lipocine Announces Positive Oral Brexanolone Quantitative EEG Results
10/09/24 Lipocine signs supply and distribution agreement with Pharmalink for Tlando
10/08/24 Lipocine Announces Supply and Distribution Agreement with Pharmalink to Commercialize TLANDO® in the Gulf Cooperation Council (GCC) Countries
10/02/24 Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management on October 16, 2024
09/30/24 Lipocine to Present at H.C. Wainwright 8th Annual MASH Investor Conference
09/05/24 Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek®
08/27/24 Lipocine to Present at H.C. Wainwright 26th Annual Global Investment Conference
08/08/24 Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2024
08/08/24 Lipocine: Q2 Earnings Snapshot
06/25/24 Lipocine Announces LPCN 1154 Meets Bioequivalence with IV Brexanolone in Pivotal Study
06/10/24 Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL Congress 2024
06/06/24 Lipocine (LPCN) Is a Great Choice for 'Trend' Investors, Here's Why
05/28/24 7 Penny Biotech Stocks to Triple Your Investment
05/21/24 Here's Why Momentum in Lipocine (LPCN) Should Keep going
05/09/24 Lipocine Announces Financial Results for the First Quarter Ended March 31, 2024
05/08/24 Lipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024
LPCN Chatroom

User Image BioAB Posted - 1 day ago

$LPCN December - NDA filing with FDA January - Payment from Verity February - Possible reply from FDA on 1154 action date. March - if no reply on Feb, then this month reply from FDA. Also Q4 results. I’m keep adding at these levels.

User Image CliffordCapital Posted - 1 day ago

$LPCN 9$ with NDA in dec?! Can we do it?

User Image BioAB Posted - 1 day ago

$LPCN added more about 5k shares left to add.

User Image BioAB Posted - 2 days ago

$LPCN slowly getting back to 54k, added back 1.5k.

User Image EMINENZ Posted - 2 days ago

$LPCN this is flying next year. get your cheapies.

User Image brunoq14 Posted - 3 days ago

$LPCN Apparently I missed it when Lipocine got Fast Track for1144. Just read about it today.

User Image Michael_ReeD12 Posted - 3 days ago

$LPCN

User Image BioAB Posted - 5 days ago

$LPCN https://ir.lipocine.com/2024-11-18-Lipocine-Announces-Publication-and-Discussion-of-LPCN-1148-Manuscript-at-The-Liver-Meeting-2024-Editors-Cut-Session

User Image Tothemoonemoji Posted - 5 days ago

$LPCN Anyone have any insight as to why this is suddenly selling off?

User Image BioAB Posted - 1 week ago

$LPCN give or take about 45 days till NDA for PPD, likely hear back in 60 days so puts us in end of Feb maybe March. I think it would be a 10 month. Jan 2026 likely action date. Run up usually starts up 6-7 months before action date. Of course Jan is when we get payment from verity of 1m $. We also have Q4 / 10k which can include the payments from the new partners. I expect those to be around 1-5m each. We likely could see a royalty payment from tlando. Of course we can target other geographic areas for tlando maybe Europe, APAC, etc. Then we have potential of 2401, if they figure out funding. $SAGE

User Image brunoq14 Posted - 1 week ago

$LPCN Getting close to filing the NDA for 1154. Patel recently said it would be before the end of the year. That doesn't necessarily imply waiting until the last minute. They were doing some tests, but that should be done by now.

User Image PharmaExpert Posted - 1 week ago

$AKBA, $SYRS, $PBYI, $GOVX, $LPCN 🔥🔥🔥🔥🔥

User Image CliffordCapital Posted - 1 week ago

$LPCN bought starter… hard to collect damn

User Image Pedelco Posted - 1 week ago

$LPCN come on, back to 10$ 🤘

User Image BioAB Posted - 2 weeks ago

$LPCN bring it to 3s please, I will buy 10k shares.

User Image bavramidis Posted - 2 weeks ago

$LPCN https://ir.lipocine.com/2024-11-07-Lipocine-Announces-Financial-Results-for-the-Third-Quarter-Ended-September-30,-2024

User Image brunoq14 Posted - 2 weeks ago

$LPCN A Type C meeting with the FDA can deal with any general questions about the development and review of a drug which are not specifically reserved for another meeting type. I hope that Patel and the FDA can figure out some way to move 1148, a potentially lifesaving drug, forward expeditiously without breaking the bank.

User Image bavramidis Posted - 2 weeks ago

Based on the chart recently this seems like a buying opportunity...$LPCN

User Image amazingcrwns Posted - 2 weeks ago

$LPCN Picked up another 200. Brings my average down to 8.224. Still hoping to pick up 800 more to reach my new target position before the pdufa run next year.

User Image skiskee Posted - 2 weeks ago

$LPCN very positive news and results. Moving in the right direction!

User Image amazingcrwns Posted - 2 weeks ago

$LPCN order filled. Picked up another 300 shares.

User Image Tothemoonemoji Posted - 2 weeks ago

$LPCN Just read the whole thing, wasn't seeing any details about the NDA filing for this quarter. Anyone see if it's mentioned anywhere?

User Image BioAB Posted - 2 weeks ago

$LPCN Quarterly results : https://app.quotemedia.com/data/downloadFiling?webmasterId=101533&ref=318694753&type=HTML&symbol=LPCN&cdn=577639a306a15e045f237c8259e20bb1&companyName=Lipocine+Inc.&formType=10-Q&dateFiled=2024-11-07

User Image Chrisdel Posted - 2 weeks ago

$LPCN “Under the Verity License Agreement with Verity Pharma, during the three months ended September 30, 2024, the Company did not recognize any royalty revenue” Uh what?

User Image Chrisdel Posted - 2 weeks ago

$LPCN I wouodve assumed earnings release today but I guess if they don’t release tomorrow then we can expect them next Wednesday

User Image brunoq14 Posted - 2 weeks ago

$LPCN. The new New Yorker magazine has an article by the husband of a woman who, suffering from PPD, killed their three young children.

User Image FlexTrading_ Posted - 2 weeks ago

XYLO IS SQUEEZING!!!! $LPCN $RSLS $BDRX $IBRX ,

User Image Bornjever Posted - 2 weeks ago

$LPCN why the hold up on news ???

User Image derekrruff Posted - 2 weeks ago

$LPCN

User Image steven1x Posted - 2 weeks ago

$LPCN if missed https://app.quotemedia.com/data/downloadFiling?webmasterId=101533&ref=318690421&type=HTML&symbol=LPCN&cdn=274e58a7defca358c5f469d3f15c82ac&companyName=Lipocine+Inc.&formType=8-K&dateFiled=2024-11-05#ex99-1.htm

Analyst Ratings
Cantor Fitzgerald Overweight Jul 27, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Patel Mahesh V. CEO and President CEO and President May 25 Buy 5.03 8,706 43,791 107,418 05/25/23
Patel Mahesh V. CEO and President CEO and President Mar 24 Buy 0.32 150,000 48,000 1,678,090 03/24/23
Ono Richard Dana Director Director Mar 20 Buy 0.34 4,000 1,360 14,125 03/20/23
Papapetropoulos Spyros Director Director Nov 22 Buy 0.47 21,739 10,217 21,739 11/28/22
Patel Mahesh V. CEO and President CEO and President May 16 Buy 0.7699 50,000 38,495 1,303,090 05/16/22
Higuchi John W. Director Director Jan 04 Sell 1.35 6,700 9,045 693,548 01/04/21